PT  - JOURNAL ARTICLE
AU  - Lorenzo, Andrea De
AU  - Kasal, Daniel Arthur B.
AU  - Tura, Bernardo Rangel
AU  - Lamas, Cristiane da Cruz
AU  - Rey, Helena Cramer Veiga
TI  - Acute cardiac injury in patients with COVID-19
AID  - 10.1101/2020.05.18.20105866
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.05.18.20105866
4099  - http://medrxiv.org/content/early/2020/05/22/2020.05.18.20105866.short
4100  - http://medrxiv.org/content/early/2020/05/22/2020.05.18.20105866.full
AB  - Introduction Cardiac complications of COVID-19 are potentially life-threatening. The occurrence of myocardial injury in the context of COVID-19 is multifactorial and has generated increasing interest.Methods A systematic review with meta-analysis of the literature was performed. MEDLINE and EMBASE were searched. Two independente reviewers evaluated the selected manuscripts for the outcome “myocardial injury”, defined by troponin elevation above the 99th percentile. Study heterogeneity and risk of bias were evaluated.Results Eight studies, with a total of 1229 patients, were included. The frequency of myocardial injury was 16% (95% CI: 9% - 27%). The heterogeneity among studies was high (93%). Conclusions: Myocardial injury may occur in patients with COVID-19, with a frequency of 16% among current studies. Continuous research is needed to update these findings, as the pandemic evolves, and to define the implications of myocardial injury in the context of this infection.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThere was no funding for this workAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data referred to in the manuscript are available (the manuscript is a meta-analysis of current literature).